Skip to main content
OpenTrials

Clinical trial condition

Cytomegalovirus Infections

Explore clinical trials studying Cytomegalovirus Infections. Study availability and eligibility vary by location and protocol.

129 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Cytomegalovirus Infections trial results

Completed

IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients

NCT00294515

Conditions
Cytomegalovirus Infections, DNA Virus Infections, Herpesviridae Infections, +2 more
Locations
  • Uni of Alabama At Birmingham Birmingham, Alabama, United States
  • National Institute of Transplantation Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Ucsd Medical Center; Kidney Transplantation San Diego, California, United States
View all 80 locations
View Trial Details
Completed

gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females

NCT00133497

Conditions
Cytomegalovirus Infections, DNA Virus Infections, Herpesviridae Infections, +2 more
Locations
  • Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati, Ohio, United States
  • Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center Nashville, Tennessee, United States
  • The University of Texas Medical Branch - Sealy Center for Vaccine Development (SCVD) Galveston, Texas, United States
  • The University of Texas Health Science Center - Pediatrics Houston, Texas, United States
View Trial Details
Completed

A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients

NCT01753167

Conditions
Cytomegalovirus Infections, DNA Virus Infections, Herpesviridae Infections, +2 more
Locations
  • UCLA; Kidney & Pancreas Transplantation Los Angeles, California, United States
  • California Inst. of Renal Research San Diego, California, United States
  • Univ of CA San Francisco; Kidney Transplant Service San Francisco, California, United States
  • University of Colorado Health Sciences Center; Dept of Medicine Denver, Colorado, United States
View all 39 locations
View Trial Details
Completed

Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive

NCT02076971

Conditions
Cytomegalovirus Infections, DNA Virus Infections, Herpesviridae Infections, +2 more
Locations
  • Hospital Universitario A Coruña A Coruña, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario Reina Sofía Córdoba, Spain
  • Hospital Universitario 12 de Octubre Madrid, Spain
View Trial Details

Related conditions